03 June 2024
The procedures to expedite drug registration and obtain permits for drug use in treating patients, including those with coronavirus, will be extended for at least another year, as announced by Deputy Minister of Health of the Russian Federation, Sergei Glagolev.
According to him, 14 drugs have been registered in Russia under the accelerated registration procedure, four of them are Russian.
Expediting the process of obtaining permits for using drugs to treat patients with coronavirus and registering medical products at state level allows for the swift introduction of essential goods to combat the epidemic.
Print06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
87% of cancer patients give positive ratings for medical care quality
18 September 2024
The Russian market of fillers and biorevitalizers grew by 21% in the first half of 2024
18 September 2024
Pharma’s Patient Reach Problem: Billions Still Left Behind
17 September 2024
17 September 2024